NOVOA
Novatti Group Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Novatti Group Limited - Option Expiring 31-Dec-2027
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.00
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in NOVOA
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in NOVOA
N/A
NOVOA investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in NOVOA also invest in...
Want more shares? Try these...
Noxopharm Ltd. engages in the research and development of drugs. The company is headquartered in Castle Hill, New South Wales. The company went IPO on 2016-08-09. The company is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. The company utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.
🙌 Performance (5Yr p.a)
-12.82%
📊 Share price
$0.09 AUD
🧬 BIOTECHNOLOGY
NewPeak Metals Ltd. engages in coal and lithium exploration in Argentina, oil and gas in Australia, and gold exploration in U.S. Its projects include cachi gold, san Jorge lithium brine and las openas gold. The company is headquartered in Brisbane, Queensland. The company went IPO on 2011-04-11. The firm has gold exploration assets in three of the mining jurisdictions globally: Finland, Argentina and New Zealand. The company has a suite of gold projects in a region in Finland which hosts three gold mines, Orivesi, Jokisivu and Kaapelinkulma. The Las Openas Gold Project is located in the province of San Juan, with a lease area of approximately 1,462 hectares. The Cachi Gold Project is a Caldera hosted epithermal gold vein system spanning approximately 10 kilometers across and five kilometers in width. The company owns a 75% stake in the Cap Burn Gold Project, in Otago, New Zealand, through an earn-in joint venture with Mineral Rangahau Joint Venture. The company has 100% ownership in several other gold properties, between OceanaGold’s Macraes Mine in the east, and the Santana-Matakanui Bendigo-Ophir project in the west. The company also has a group of mineral and tungsten exploration assets in Sweden.
🙌 Performance (5Yr p.a)
60.00%
📊 Share price
$0.01 AUD
📈 HIGH PRICE GROWTH
⛏️ MINING
Novatti Group Ltd. provides software technology and systems integration services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2016-01-18. The Company’s solutions include issuing, acquiring, processing, and billing. Its segments include Payments AU and NZ, Payments International, and Technology Solutions. Payments AU/NZ segment include Payments Acquiring, Card Issuing, Cross Border Payments and Novatti Billpay. Payments International segment include ATX Payments (Malaysia) and Flexepin Payments (Europe). Technology Solutions include enterprise, automation and billing software. The company provides cash voucher services to a global customer base to enable cash to be transferred to a digital form for use on e-commerce trading and services Websites, with operations in Australia and Canada and pin-point solutions for other countries and regions. The company also offers Cross-border Payments provides wholesale payment facilitation in and out of Australia for its own affiliated agents.
🙌 Performance (5Yr p.a)
-17.37%
📊 Share price
$0.03 AUD
🤖 TECHNOLOGY